Shield Bio
Bringing 3rd generation, nanopore sequencing to healthcare to solve…
Shield Bio is a precision medicine company with a
proprietary platform that enables reliable nanopore
sequencing in under a minute, in a clinical setting. It is
focused on bringing 3rd generation or "nanopore"
sequencing into clinical use to deliver on the promise of
precision medicine. Shield is initially using the technology to
improve the treatment of infectious disease and address the
unmet clinical need of sepsis, which kills 300,000 people a
year in the US alone.
